tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
LENZ
LENZ Therapeutics
RESEARCH TOOLSreports
Want to see LENZ full AI Analyst Report?

LENZ Therapeutics (LENZ) Stock News & Sentiment

397 Followers
LENZ Therapeutics: Early VIZZ Launch Traction Supports Buy Rating Despite Trimmed Near‑Term Outlook
Premium
Ratings
LENZ Therapeutics: Early VIZZ Launch Traction Supports Buy Rating Despite Trimmed Near‑Term Outlook
10d ago
LENZ
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
Premium
Company Announcements
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
1M ago
LENZ
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
Premium
Ratings
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
1M ago
LENZ
Is LENZ a Buy, Before Earnings?
Premium
Pre-Earnings
Is LENZ a Buy, Before Earnings?
1M ago
LENZ
LENZ Therapeutics: Early VIZZ Launch, Targeted DTC Campaign, and Differentiated Presbyopia Profile Underpin Buy Rating
Premium
Ratings
LENZ Therapeutics: Early VIZZ Launch, Targeted DTC Campaign, and Differentiated Presbyopia Profile Underpin Buy Rating
4M ago
LENZ
Robust Early Adoption, Favorable Safety Profile, and Upcoming DTC Campaign Support Buy Rating on VIZZ
Premium
Ratings
Robust Early Adoption, Favorable Safety Profile, and Upcoming DTC Campaign Support Buy Rating on VIZZ
4M ago
LENZ
Overreaction to LENZ Therapeutics’ Stock Decline Presents Buying Opportunity Despite Isolated Retinal Tear Incident
Premium
Ratings
Overreaction to LENZ Therapeutics’ Stock Decline Presents Buying Opportunity Despite Isolated Retinal Tear Incident
5M ago
LENZ
More LENZ News >

LENZ News on the Web

Squarepoint Ops LLC Acquires Significant Stake in LENZ Therapeutics Inc
GuruFocus News
Bullish
LENZ Therapeutics Insiders Go on a Buying Spree, Signaling Big Confidence Ahead
TipRanks News
Neutral
Insider Buying: Jeffrey George Acquires Shares of LENZ Therapeutics Inc (LENZ)
GuruFocus News
Neutral
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
TipRanks News
Bullish
Lenz Therapeutics price target lowered to $26 from $52 at Citi
TipRanks News
Bearish
Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), LENZ Therapeutics (LENZ) and Sarepta Therapeutics (SRPT)
TipRanks News
Bullish
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
TipRanks News
Bullish
Lenz Therapeutics price target lowered to $29 from $35 at BofA
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
LENZ
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LENZ’s Media Buzz Sentiment?
1 articles about LENZ were published this week. In an average week, 3.75 articles are published.
    What is LENZ’s weekly average amount of articles?
    In an average week, 3.75 articles about LENZ are published.
      What is LENZ’s News Sentiment?
      100% of articles about LENZ were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week